Introduction
\bodyAlthough vaccination plays a tremendous role in the protection against infectious diseases, there are many pathogens for which even the immunity acquired after natural infection does not fully protect against re-infection and disease. Therefore, vaccines which offer superior protection compared to the one following natural infection are needed. Most of the current vaccines induce protective antibodies but often fail to confer sufficient protection.
An alternative approach is to develop vaccines which are based on the induction of cellular immunity in general and cytotoxic CD8 T cells in particular (1) .
Cytomegaloviruses (CMVs) are excellent inducers of the CD8 T cell response, in spite of having numerous immunoevasion strategies aimed at compromising antigen presentation by MHC class I molecules (2) . Preferentially, CMVs induce the effector arm of memory CD8 T cells (3) . This, together with a large genome allowing the insertion of multiple foreign genes, makes CMVs attractive vaccine vectors. The outstanding capacity of specific CD8 T cells induced by CMV vectors was proven by studies demonstrating the role of tissue resident effector memory CD8 T cells in the protection against challenge infection (4, 5) . The suitability of CMV as a vaccine vector was further emphasized in a recent study by Hansen et al (6) .
NKG2D is a receptor expressed on several lymphocyte subsets, with a predominant role in activation of NK cells. In addition, NKG2D has a co-stimulatory role on CD8 T cells (7) . The ligands for the NKG2D receptor are several molecules induced by stress or cell transformation. In mice, NKG2D ligands comprise the RAE-1 family (RAE-1α-ε), H60
family (H60a-c) and MULT-1 proteins (8) . The significance of NKG2D signaling in immune response to CMV infection is best illustrated by numerous strategies employed by CMVs to evade the function of this receptor (9) . We have recently shown that infection of mice with MCMV expressing RAE-1γ elicits a strong and long-lasting MCMV specific CD8 T cell response, despite a dramatic virus attenuation as a consequence of efficient NK cell control (10) .
Here we demonstrate that MCMV expressing RAE-1γ has a tremendous potential for boosting the efficiency of CD8 T cells directed against a vectored antigenic peptide. We show that CMV expressing RAE-1γ and immunodominant CD8 T cell epitope of LM listeriolysin O (LLO) or ovalbumin derived SIINFEKL, induces a superior epitope-specific and durable protective CD8 T cell response. Moreover, our study indicates the existence of another, so far unknown immune function of RAE-1γ beyond engagement of NKG2D. Altogether, our data set the stage for powerful new approach in designing T-cell based vaccines.
Results
CMV expressing RAE-1and listeriolysin epitope induces a strong listeriolysin-specific CD8 T cell response. To test the potential of using MCMV expressing RAE-1γ as a vector, we have constructed a virus expressing immunodominant CD8 T cell epitope of LM listeriolysin O 91-99 (LLO) (11) on the backbone of RAE-1γMCMV (10) , where RAE-1γ was introduced in place of its viral inhibitor m152 (RAE-1γMCMVList). The LLO epitope was introduced in place of the MCMV immunodominant CD8 T cell epitope m164 [167] [168] [169] [170] [171] [172] [173] [174] [175] (Fig. 1A) . MCMV expressing the LLO epitope only (MCMVList) was used as control. Neither of the genetic modifications affected viral growth kinetics in vitro ( Fig. S1A and S1B ). As shown by the viral load in spleen and lungs of infected mice, RAE-1γMCMVList, but not MCMVList was severely attenuated in BALB/c (H-2 d ) mice (Fig. 1B) . In spite of the striking attenuation, RAE-1γMCMVList induced a stronger LLO-specific CD8 T cell response compared to MCMVList (Fig. 1C and Fig. S1C ). To exclude the possibility that the robustness of the CD8 T cell response after infection with RAE-1γMCMVList vector was restricted to a single MHC I haplotype, C57BL/6 (H-2 b ) mice were infected with RAE-1γMCMV expressing the H-2K b restricted peptide SIINFEKL (RAE-1γMCMV-SIINFEKL) (12) (Fig. 1A) . The infection with RAE-1γMCMV-SIINFEKL resulted in a higher frequency of SIINFEKL-specific CD8 T cells compared to the infection with MCMV expressing SIINFEKL only (Fig. 1D) . The CD8 T cell response to some, but not all MCMV immunodominant epitopes, was also superior in RAE-1γMCMV-SIINFEKL infected mice (Fig. S1D) . Altogether, the results demonstrated the capacity of MCMV expressing RAE-1γ
to potentiate the CD8 T cell response directed against vectored CD8 T cell epitopes.
Superior protection against a challenge infection in mice immunized with RAE-
1γMCMV expressing antigenic peptides. LLO-specific CD8 T cells play a major role in the protection against LM in BALB/c mice (11, 13) . To prove the efficiency of RAE1γMCMVList as a vaccine, BALB/c mice were immunized with RAE-1γMCMVList,
MCMVList or wt MCMV and tested for protective capacity against a challenge infection with LM three weeks later ( Fig. 2A ). Mice were sacrificed four days post challenge and analyzed for bacterial load in the spleen and liver (Fig. 2B) . Naïve mice and mice immunized with wt MCMV showed higher bacterial loads in both organs and significant proportion of them and TNF-α production after challenge infection with LM (Fig. 2D) .
To test the efficiency of RAE-1γ expressing MCMV vectors in a second model, C57BL/6 mice were primed with viruses expressing SIINFEKL either with or without RAE-1 coexpression and challenged with LM expressing ovalbumin (OVA-Listeria) (Fig. 2E) . The results demonstrated superior resistance of RAE-1γMCMV-SIINFEKL immunized mice to challenge with OVA-Listeria. 3C ). When mice were challenged with higher inoculums (4x10 4 CFU/mouse), it was demonstrated that RAE-1γMCMVList vaccinated mice could still resist the challenge (Fig.   3D ). The efficient and long-lasting protective capacity of the LLO-specific CD8 T cell response in mice vaccinated with RAE-1γMCMVList was confirmed by assessing the LLO-specific CD8 T cell-mediated cytotoxicity in vivo (Fig. 3E ). Listeriolysin-specific killing was significantly higher for at least 11 months post-vaccination in mice vaccinated with RAE1γMCMVList. Altogether, it can be concluded that the herpesviral vector engineered to express the NKG2D ligand RAE-1γ provided highly efficient long-term CD8 T cell mediated protection against LM infection.
CD8 T cells represent
Better priming of CD8 T cells and attenuation of RAE-1MCMVList is a consequence of ectopic expression of RAE-1γ. Although it has been previously shown that the deletion of MCMV inhibitors of MHC class I presentation does not enhance the CD8 T cell response (3), this possibility could not be completely excluded, particularly since m152 is also a viral inhibitor of RAE-1 expression (9). To investigate whether RAE-1γ alone or also deletion of m152 enhances the potency of our viral vector, a virus expressing the LLO epitope on the backbone of the m152-deficient virus (15) (m152MCMVList) was used. m152MCMVList
showed attenuated growth in vivo, but the level of attenuation was much more pronounced with the RAE-1γMCMVList (Fig. S3A) . Furthermore, the frequency of LLO-specific CD8 T cells induced by m152MCMVList at day 8 post infection was inferior compared to the level induced by the RAE-1γMCMVList (Fig. S3B) . However, at later time points we have observed a high frequency of epitope specific CD8 T cells also in mice infected with m152MCMVList, suggesting an impact of m152 deletion. These data led us to conclude that the major mechanism behind attenuation and improved CD8 T cell response in mice infected with virus expressing RAE-1γ does not result from endogenous RAE-1γ or improved MHC-I presentation due to deletion of m152, but rather from the ectopic expression of RAE-1γ.
NKG2D independent immune function of RAE-1γNext, we wanted to investigate how RAE-1γ, in the context of MCMV vector, mediates its immune-stimulatory effects. It has been well established that co-stimulation via NKG2D plays an important role in shaping of the CD8 T cell response (7, 16) . This function may be crucial for efficient priming of CD8 T cells by RAE-1γMCMV, since MCMV downregulates co-stimulatory molecules on antigenpresenting cells as does HCMV (17, 18) . Therefore, we investigated the capacity of RAE1γMCMVList to prime CD8 T cells in the presence of blocking NKG2D antibodies. Blocking of NKG2D significantly reduced but did not completely abolish the control of RAE1γMCMVList at day 3 p.i. (Fig. 4A) . Surprisingly, we observed that CD8 T cell responses were not diminished in the presence of blocking antibodies neither in BALB/c nor C57BL/6 mice ( Fig. 4B and C) . These observations suggested an NKG2D-independent role for RAE-1γ. To ensure that our observations were not the result of insuficient blocking of RAE-1γ-NKG2D interactions, we took advantage of mice lacking the NKG2D receptor (NKG2D -/-mice) (19) . C57BL/6 mice as well as NKG2D -/-mice were i.v. infected with either wt MCMV, MCMV-SIINFEKL or RAE-1γMCMV-SIINFEKL and the virus titers in organs were determined at day 7 p.i. (Fig. 4D) . MCMV expressing RAE-1γ was attenuated not only in control C57BL/6 mice but also in NKG2D -/-mice. Moreover, in accordance with our findings after the application of blocking antibodies, we also found a higher frequency of SIINFEKL specific CD8 T cells in NKG2D -/-mice after infection with RAE-1γMCMV-SIINFEKL, compared to MCMV-SIINFEKL (Fig. 4E) . This difference did not depend on the absence of m152 since RAE-1γMCMV-SIINFEKL was much more attenuated than m152MCMV-SIINFEKL, in both wt and NKG2D -/-mice (Fig. 4F ). These findings suggested that RAE-1γ has an immune-stimulatory role beyond the engagement of NKG2D.
Next we tested whether NKG2D-independent triggering of CD8 T cells in RAE-1γMCMV- comparison to wt MCMV, the virus expressing RAE-1γ affects the frequency of DCs in the spleen to a much lesser extent (10) (Fig. 6A) . Although the deletion of m152 on its own prevented the loss of DCs in spleen compared to wt MCMV, both DCs subsets were preserved to a much higher level in mice infected with RAE-1γMCMVList. The preserved frequency of DCs in RAE-1γMCMVList infected mice was not a consequence of NK cells disfunction since we showed their functional capacity was completely preserved (Fig. S4) . The preservation of DCs during early days p.i. corresponded to the enhanced priming of CD8 T cells in RAE-1γMCMVList infected mice, which was illustrated by the higher frequencies of LLO-specific CD8 T cells (Fig. 1C and Fig. S1C ) and a higher proliferation capacity of CD8
T cells (Fig. 6B ). This was in inverse correlation with level of IFN-α in the sera of RAE1γMCMVList-infected mice (Fig. 6C) . Thus, we can conclude that the expression of RAE-1γ
by MCMV promotes the priming of CD8 T cells by preserving antigen-presenting cells.
Although it is generally assumed that cross-presentation plays a dominant role in the priming of CD8 T cells during MCMV infection (3, 22, 23) , we proposed that priming in mice infected with MCMV expressing RAE-1γ would not be dependent on cross-presentation, since a lowered antigenic load should, at least in theory, reduce the cross-priming capacity of such virus. To test this hypothesis, we used 3d mice defective in TLR3, TLR7 and TLR9
signaling which are unable to cross-present foreign antigens (24) . 3d mice were infected with either MCMV-SIINFEKL or RAE-1γMCMV-SIINFEKL and the frequency of SIINFEKLspecific as well as MCMV-specific (M45) CD8 T cells was determined 7 days later (Fig. 6D ).
Although both viruses induced an epitope-specific CD8 T cell response, the one induced by RAE-1MCMV-SIINFEKL was slightly stronger than the one in mice infected with MCMV-SIINFEKL. Additionally, the priming capacity of RAE-1γMCMV vector was assessed in Batf3 -/-mice deficient for CD8α + DCs, which can present antigenic peptides through direct or cross-presentation mechanisms (25, 26) . In contrast to control C57BL/6 mice and 3d mice, the priming capacity of both RAE-1γMCMV-SIINFEKL and MCMV-SIINFEKL was dramatically reduced in Batf3 -/-mice suggesting the crucial role of this specific DCs subset rather than cross-presentation as such (Fig. 6E) . However, contrary to the mice infected with MCMV-SIINFEKL, the CD8 T cell response to RAE-1γMCMV-SIINFEKL was not completely abolished in Batf3 -/-mice, suggesting some CD8α + DCs independent priming.
To investigate more directly the effect of RAE-1γ on memory CD8 T cell differentiation, naive CD8 T cells from MHC class-I restricted TCR transgenic mice (27) with a high specificity for the MCMV-derived epitope M38 were i.v. injected into C57BL/6 mice. One day later, recipient C57BL/6 mice were i.v. injected with either wt MCMV, m152MCMVor RAE-1γMCMV. On days 7 and 14 p.i. CD8 T cells from spleens ( To investigate whether this effect of RAE-1γ on the pattern of memory CD8 T cell differentiation is NKG2D dependent, NKG2D Δ/Δ mice, a second NKG2D-deficient mouse line generated in our lab (29) , were crossed on OT-1 TCR transgenic C57BL/6 mice (30). MCMV efficiently downregulates co-stimmulatory molecules in infected cells which may result in deficient priming of CD8 T cells (17) . Because NKG2D can also serve as a costimulatory receptor, we designed our RAE-1γMCMV vector to circumvent viral evasins of co-stimmulatory signaling. Our goal was to attenuate in vivo replication of our vector, while simultaneously enhance its capacity to prime CD8 T cells. The molecular communication between DCs and CD8 T cells regulates both the magnitude and the quality of the resulting CD8 T cell response. Thus, improved antigen presentation with MCMV expressing RAE-1γ
can, at least in part, be explained by a preserved frequency of DCs and by rescuing their costimmulatory capacity through RAE-1γ. It is worth emphasizing that preserved CD8α + DC subset rather than cross-presentation mechanism is the dominant factor for CD8 T cell priming in mice infected with the RAE-1γMCMV vector. This is in line with more recent findings demonstrating that MCMV-specific CD8 T cell priming is dependent on the CD8α + DC subset rather than on cross-presentation (25) .
The promoting effect of NKG2D ligands on specific CD8 T cell responses is not without precedent in the literature: it has been shown that NKG2D ligands RAE-1 and H60
ectopically expressed on tumor cell lines strongly enhance the generation of tumor specific CD8 T cell response and are able to protect immunized host against a challenge with the original tumor lines lacking the NKG2D ligands (35) . Here we demonstrated that MCMV expressing RAE-1γ has improved priming potential also in NKG2D -/-mice, suggesting an NKG2D independent function of RAE-1γ. Further studies are needed to define the molecular basis of this NKG2D independent function of RAE-1γ. It is also possible that this NKG2D independent immune function is expressed or even induced only in NKG2D deficient mice.
Yet, the inability of NKG2D blocking to abolish the effect of RAE-1γ on CD8 T cell priming argues in favour of a constitutive existance of NKG2D independent function for RAE-1γ.
Priming in the absence of a systemic inflammation accelerates the transition of earlymemory to late-memory CD8 T cells (36) . 
